• Journal of Chest Surgery
• /
• 제27권6호
• /
• pp.427-434
• /
• 1994

A clinical study was designed to evaluate myocardial metabolism during continuous cold blood cardioplegia [Group A, n=10] in comparison with continuous warm blood cardioplegia [Group B, n=10], in a prospective randomized manner. Myocardial metabolism was assessed in two ways: either by collecting blood from coronary sinus before and after cardiopulmonary bypass or by collecting blood from cardioplegic affluent and effluent simultaneously at the beginning and at the end of cardioplegia. The former samples were assayed for gas analysis, lactic acid and cardiac enzyme [CK, LDH, SGOT] and the latter for gas analysis and lactic acid as a maker of anaerobic metabolism. The results were as follows. 1] Myocardial metabolism was shown to be continued in the state of cardioplegia at lower temperature as evidenced by high oxygen extraction of cardioplegic solution in Group A. 2] Anaerobic metabolism occurring at lower temperature in spite of continuous cold blood cardioplegia can be significantly reduced by continuous perfusion of normothermic blood cardioplegics as evidenced by significant reduction of lactate production in Group B [p〈0.05]. 3] Better myocardial protection can be achieved by employing continuous warm blood cardioplegia as evidenced by less cardiac enzyme release in Group B after cardiopulmonary bypass.

• Journal of Chest Surgery
• /
• 제34권10호
• /
• pp.797-799
• /
• 2001

한랭응집소는 저온에서 적혈구의 용혈 및 응집반응을 일으켜 저체온법을 이용한 개심술 시 치명적인 합병증을 일으킨다. 41세 남자 환자가 승모판 협착증을 진단 받고 외래 관찰 도중 기침과 발열 등의 폐렴증상으로 입원하여 항생제 치료 후 승모판 치환술을 받았다. 수술 도중 심정지액의 온도를 내리면서 응집현상을 관찰하고 한랭반응단백질에 의한 응집현상을 의심하여 심정지액을 온혈성으로 바꾸고 정온 체외순환으로 무사히 개심술을 마쳤으며, 수술 후 면역혈청학검사에서 한랭응집소를 확인하였기에 이를 보고하는 바이다.

• Journal of Chest Surgery
• /
• 제13권3호
• /
• pp.186-197
• /
• 1980

We attempted to evaluate the effectiveness of cold blood potassium cardioplegia [Group B] compared with that of intermittent aortic cross clamp with topical hypothermia [Group A] in each six dogs. The studies were performed under the extracorporeal circulation with moderate hypothermia by using Mongrel dogs. 1. In Group A [6], it was difficult to maintain the temperature below 20?. but in Group B [6], it was possible to maintain the temperature. 2. In blood pressure and myocardial recovery ability, Group B was more excellent than Group A. 3. There was no significant difference in Na+, Ca++ and Cl- between both groups, but in K+ level, Group A was mild decreased and Group B was nearly normal level. 4. In serum LDH level, Group A was higher than Group B, but in SGOT level there was no significance between both groups. 5. On electromicroscopical study, Group A showed severe change in mitochondria, but Group B was nearly normal view. Thus we suggest that cold blood potassium cardioplegia would be more effective than intermittent aortic cross clamp with topical hypothermia for myocardial protection in open heart surgery.

• Journal of Chest Surgery
• /
• 제17권4호
• /
• pp.587-592
• /
• 1984

Potassium cardioplegia for myocardial preservation is being used extensively in open heart surgery. This study was designed to investigate the change in serum and urine potassium before, during, after the administration of cold blood potassium cardioplegic solution containing 28-30 mEq/L [28.6\ulcorner.56 mEq/L] of potassium chloride in 6 dogs. Total potassium dose used in the study was 14.9\ulcorner.89 mEq/L [1.2 mEq/Kg]. Mean potassium level in serum was within normal limits. Urinary excretion of potassium decreased during bypass but increased after bypass and eventually exceeded the amount of potassium infused as cold blood potassium cardioplegic solution. While cold blood potassium cardioplegia is a safe and efficient method of myocardial protection, postoperative potassium level must be observed carefully in order to detect obligatory potassium excretion following open heart surgery.

• Journal of Chest Surgery
• /
• 제22권4호
• /
• pp.609-619
• /
• 1989

During aortic valve surgery, cardioplegic solution is delivered through direct cannulation of both coronary ostia. Since this approach may cause an intimal injury leading to acute dissection or late ostial stenosis, this study was undertaken to evaluate myocardial protective effect of retrograde perfusion of cardioplegia [RCSP <% RRAP] in 18 clinical cases, which were compared with antegrade perfusion of cardioplegia in 27 clinical cases. This study were investigated 1] cease and return of electromechanical activity after cardioplegia infusion 2] the myocardial temperature during operation 3] the aortic cross clamping time and total bypass time 4] frequency of DC shock for defibrillation 5] need for inotropic drugs after operation 6] electrocardiographic evidence of myocardial infarction or ventricular arrhythmia after operation 7] the enzymes activity during preoperative and postoperative period as an evaluation of myocardial ischemic injury and 8] operative mortality rate The combination of retrograde cardioplegia and topical cooling with ice slush yielded promptly hypothermia of myocardium and shorter aortic cross-clamping time compared with antegrade cardioplegia [P < 0.05]. The temperature of the interventricular septum was maintained below 20oC by continuous perfusion or intermittent perfusion of cold blood cardioplegia and other results were no statistically significant difference between the two methods [P >0.05]. This technique provides clear operative field and avoids some serious complications which are caused by coronary ostial cannulation. These results suggested that the retrograde perfusion of cardioplegia is a simple, safe, and effective means of myocardial protection during open heart surgery.

• Journal of Chest Surgery
• /
• 제15권1호
• /
• pp.35-39
• /
• 1982

Cold blood potassium cardioplegia, by two types of the infusion systems, was used in 45 patients who were undergone the open cardiac operation. Method A [in 25 patients] was the syringe infusion system and method B [in 20 patients] was the pump infusion system. Cold blood potassium cardioplegic solution was used less amount on method B than method A. Serum potassium was often increased significantly on method A as a result of excessive infusion of cold blood potassium cardioplegic solution. But method B, excessive infusion of cold blood potassium cardioplegic solution was prevented by reperfusion of the previous infused cold blood potassium cardioplegic solution through the recirculation system. Alteration of infused rate and concentration of potassium in cold blood potassium cardioplegic solution during infusion [which might be suggested on the method A] could be controlled on method B.

• Journal of Chest Surgery
• /
• 제47권2호
• /
• pp.133-136
• /
• 2014

Cold agglutinins are predominately immunoglobulin M autoantibodies that react at cold temperatures with surface antigens on the red blood cell. This can lead to hemagglutination at low temperatures, followed by complement fixation and subsequent hemolysis on rewarming. Development of hemagglutination or hemolysis in patients with cold agglutinins is a risk of cardiac surgery under hypothermia. In addition, there is the potential for intracoronary hemagglutination with inadequate distribution of cardioplegic solutions, thrombosis, embolism, ischemia, or infarction. We report a patient with incidentally detected cold agglutinin who underwent normothermic cardiac surgery with warm blood cardioplegia.

• Journal of Chest Surgery
• /
• 제19권4호
• /
• pp.549-557
• /
• 1986

In cardiac patients who received multidose cold blood potassium cardioplegia for intracardiac procedures, the intraoperative and the immediate postoperative blood potassium levels were decreased at aortic cross-clamp time below 2 hours and increased at aortic cross-clamp time above 2 hours, but they were within normal limit [not hypokalemia or hyperkalemia]. In spite of increased infusion numbers and amount of cold blood potassium cardioplegia, the postoperative blood potassium levels were similar to the postoperative levels, the immediate postoperative A-V blocks were transient and the postoperative arrhythmia were rare.

• Journal of Chest Surgery
• /
• 제48권3호
• /
• pp.164-173
• /
• 2015

Background: Hypertrophied myocardium is especially vulnerable to ischemic injury. This study aimed to compare the early and late clinical outcomes of three different methods of myocardial protection in patients with aortic stenosis. Methods: This retrospective study included 225 consecutive patients (mean age, 65{\pm}10 years; 123 males) with severe aortic stenosis who underwent aortic valve replacement. Patients were excluded if they had coronary artery disease, an ejection fraction <50%, more than mild aortic regurgitation, or endocarditis. The patients were divided into three groups: group A, which was treated with antegrade and retrograde cold blood cardioplegia; group B, which was treated with antegrade crystalloid cardioplegia using histidine-tryptophan-ketoglutarate (HTK) solution; and group C, treated with retrograde cold blood cardioplegia. Results: Group A contained 70 patients (31.1%), group B contained 74 patients (32.9%), and group C contained 81 patients (36%). The three groups showed significant differences with regard to the proportion of patients with a New York Heart Association functional classification ${\geq}III$ (p=0.035), N-terminal pro-brain natriuretic peptide levels (p=0.042), ejection fraction (p=0.035), left ventricular dimensions (p<0.001), left ventricular mass index (p<0.001), and right ventricular systolic pressure (p <0.001). Differences in cardiopulmonary bypass time (p=0.532) and aortic cross-clamp time (p=0.48) among the three groups were not statistically significant. During postoperative recovery, no significant differences were found regarding the use of inotropes (p=0.328), mechanical support (n=0), arrhythmias (atrial fibrillation, p=0.347; non-sustained ventricular tachycardia, p=0.1), and ventilator support time (p=0.162). No operative mortality occurred. Similarly, no significant differences were found in long-term outcomes. Conclusion: Although the three groups showed some significant differences with regard to patient characteristics, both antegrade crystalloid cardioplegia with HTK solution and retrograde cold blood cardioplegia led to early and late clinical results similar to those achieved with combined antegrade and retrograde cold blood cardioplegia.

• Journal of Chest Surgery
• /
• 제36권4호
• /
• pp.242-254
• /
• 2003

상온에서 단기간의 심근 허혈이 가해질 때 허혈 전처치가 심근기능의 보호에 효과가 있다는 사실은 어느 정도 증명되었지만 저온의 심근 보호액을 이용하여 심장을 정지시킨 후 $25^{\circ}C$의 중등도 저체온 상태에서 간헐적으로 심근 보호액을 주입하며 장시간 허혈 상태에 노출시키는 일반적인 심장수술을 시행하는 경우에 허혈 전처치가 효과가 있는지에 대해서는 연구가 부족한 상태이며 또한 연구결과에 따라 많은 이견이 있다. 본 실험에서는 상온에서의 허혈과 중등도 저체온법을 사용하며 심근 보호액의 간헐적 주입을 병행하는 일반 심장 수술에서 허혈 전처치가 심근 보호에 미치는 효과를 비교하기 위해 실험을 진행하였다. 대상 및 방법： $25^{\circ}C$에서 St. Thomas hospital 심근 보호액을 사용한 경우와 상온에서 심근 보호액 없이 허혈을 받은 경우 각각에서 허혈 전처치의 효과를 비교하였다. 모든군의 심장을 20분간 $37^{\circ}C$의 Krebs 용액으로 관류시키고, 제1군은(n=6)은 허혈 전처치로 $37^{\circ}C$에서 3분간의 허혈 및 5분간 재관류를 두 차례 받은 후, $4^{\circ}C$의 심근 보호액을 20분마다 반복해 주입하며 120분간 $25^{\circ}C$의 중등도 저체온 상태를 유지하였다. 제2군(n=6)은 제1군에 대한 대조군으로 허혈 전처치를 하지 않은 상태에서 역시 120분간 $25^{\circ}C$상태를 유지하며 20분마다 심근 보호액을 반복해 주었다. 제1, 2군 모두 허혈기가 끝난 후 $37^{\circ}C$의 Krebs 용액으로 30분간 재관류하며 결과를 측정하였다(제1, 2군： 저온 심근 보호액군). 상온에서의 허혈군으로 $37^{\circ}C$를 유지하며 전반적 허혈을 받은 두 군을 설정하였다. 제3군(n=6)은 3분 허혈, 5분 재관류로 허혈 전처치 후 $37^{\circ}C$에서 30분간 허혈 상태를 유지 후 30분간 재관류하였고, 제4군(n=6)은 제3군에 대한 대조군으로 허혈 전처치 없이 30분간 허혈 후 30분간 재관류하며 결과를 측정하였다(제3, 4군: 상온 심정지군). 결과: 저온 심근 보호액 군에서는 허혈전처치를 시행 후 심근 보호액을 주입한 군(제1군)과 허혈 전처치 없이 심근 보호액을 주입한 대조군(제2군)의 비교에서 관상동맥 관류량, 심박동수, 좌심실내압, 좌심실압과 맥박수를 곱한 값, 좌심실압 순간 변화율 및 CPK, LDH의 비교 모두에서 통계적으로 유의한 차이를 볼 수 없었다(p=NS). 상온 심정지 군에서는 허혈 전처치 후 $37^{\circ}C$에서 허혈을 유지한 군(제3군)과 허혈 전처치 없이 허혈을 유지한 대조군(제4군)의 비교에서 허혈 전처치를 시행한 군이 좌심실 수축기압, 좌심실압과 맥박수를 곱한값, 좌심실 이완기압, 좌심실압 순간 변화율 등이 허혈 전처치를 시행치 않은 군보다 유의하게 호전되었고 CPK, LDH의 변화에서도 유의한 차이를 보여 허혈 전처치가 심근의 기능적 회복 및 심근 보호에 효과가 있음을 보았다(p<0.05). 결론: 이상의 결과에서 쥐의 심장을 이용한 실험 시 허혈 전처치가 상온에서의 심근 허혈과 재관류 시에는 심근기능 회복에 효과가 있으나 중등도 저체온법과 간헐적 심근 보호액의 주입 하에서 시행한 심장의 재관류에는 심근보호 효과가 없음을 보았다.